Specific features of the immune status and blebbing of the plasmatic membrane of lymphocytes patients with urolithiasis complicated by the pyelonephritis

Urologiia ◽  
2019 ◽  
Vol 5_2019 ◽  
pp. 60-63
Author(s):  
A.G. Berezhnoy Berezhnoy ◽  
F.A. Sevryukov Sevryukov ◽  
Yu.Yu. Vinnik Vinnik ◽  
F.P. Kapsargin Kapsargin ◽  
◽  
...  
2018 ◽  
Vol 26 (6) ◽  
pp. 689-696
Author(s):  
Yu.S. Vinnik ◽  
◽  
S.S. Dunaevskaya ◽  
D.A. Antufrieva ◽  
V.V. Deulina ◽  
...  

2004 ◽  
Author(s):  
B. J. Gumilevsky ◽  
V. N. Tzygan ◽  
O. P. Gumilevskaya
Keyword(s):  

2014 ◽  
Vol 9 (S 01) ◽  
Author(s):  
O D'Orlando ◽  
R Puff ◽  
A Henniger ◽  
S Krause ◽  
F Haupt ◽  
...  

2019 ◽  
Vol 322 (2) ◽  
pp. 27-31
Author(s):  
V.V. Fedyuk ◽  
◽  
E.I. Fedyuk ◽  
A.A. Tyutyunnikova ◽  
◽  
...  
Keyword(s):  

2020 ◽  
pp. 4-6

The present study was carried out in the Labs of collage of education for pure science, during period from January 2017 to endDecember of the same year. The immune status investigates for CLpatients by measuring the levels of cytokines (IL6and IL10) in sera using a technique enzyme-linked immune Sorbent adsorptive (ELISA). The study included 120 subjects with (60 CLpatientsL.majar and 60 CLpatients L. tropica with and (30) were healthy control. Increased mean Serum level of IL6 was in the observed in the total patients as compared to control Subjects (224.53pg/ml,70.70pg/ml), the result indicate there was significant difference at (p<0.05) ,such observation was consistent in the patient infected with L.majar and L. tropica (104 .90 pg/ml and 112.78 pg/ml) respectively. The results of the IL10 showed significant difference at (p<0.05)increased of mean Serum level in the total CL patients as compared to control Subjects(226.90 pg/ml 46.77pg/ml,).Ahighly significant difference at (p<0.05) increased observed in patients group infected with L.majar and followed by patients group infected L. tropica (112.78pg/ml and 114.12pg/ml) respectively.These results revealed that the excessive presence of cytokines might play a role in CL patients.


2017 ◽  
Vol 126 (3) ◽  
pp. 229-238 ◽  
Author(s):  
H Zha ◽  
G Lewis ◽  
A Alfaro ◽  
S Wang ◽  
Y Dong ◽  
...  

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1494-1499
Author(s):  
Shahid Ahmad Siddiqui

The episode of Covid19 (CORONA VIRUS) has become one of the greatest worldwide dangers around the world, which has now tainted over 1.7 million individuals with deaths of over 100,000 lives far & wide. Under these extraordinary conditions, there are no entrenched rules for cancer patients. The danger for genuine infection & passing in CORONA VIRUS cases increments with propelling age & existing co-morbid medical issue. After the rise of primary suspects in China during last month of 2019, enormous exploration endeavors have been in progress to comprehend the instruments of infectivity & contagiousness of coronavirus, a lethal infection liable for wretched endurance results. To limit the death rate, it gets judicious to distinguish indications quickly & utilize medicines suitably. Despite the fact that no fix has been set up, different clinical preliminaries are in progress to decide the most ideal system. Overseeing patients with cancer in these conditions is a fair task, considering their weak immune status & their ill health. Through this thorough audit, we talk about the effect of CORONA VIRUS on wellbeing & the immune system of who are infected, assessing the most recent care plan draws near & progressing clinical preliminaries. Also, we talk about difficulties confronted while treating cancer patients & propose possible ways to deal with these weak populace during pandemic.


Sign in / Sign up

Export Citation Format

Share Document